… that treat the same diseases as Tepezza and Krystexxa do. Amgen … , according to the FTC.
As part of the deal, attorneys … scrutinize" the acquisition and the then-pending merger of Indivior and … 's $43 billion acquisition of cancer drug developer Seagen …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
